Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07354217 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation

Study acronym: PFA_workflow
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jan 1, 2026 to Jun 1, 2026v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the efficacy and safety of intravenous lidocaine in reducing diaphragmatic contraction and suppressing the cough reflex during pulsed field ablation procedures.
Trial Details
NCT Number NCT07354217
Lead Sponsor National Taiwan University Hospital
Collaborators: Johnson & Johnson
Conditions Pulsed Field Ablation, Lidocaine
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov